Weatherstone Capital Management’s Pfizer PFE Stock Holding History

Weatherstone Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,472	Closed	-$312K	–	123
2018 Q4	$312K	Buy	+7,472	New	+$310K	0.08%	133
2017 Q1	–	Sell	-8,229	Closed	-$254K	–	99
2016 Q4	$254K	Hold	8,229	–	–	0.17%	67
2016 Q3	$264K	Hold	8,229	–	–	0.22%	75
2016 Q2	$275K	Hold	8,229	–	–	0.23%	67
2016 Q1	$231K	Hold	8,229	–	–	0.17%	72
2015 Q4	$252K	Hold	8,229	–	–	0.29%	64
2015 Q3	$245K	Hold	8,229	–	–	0.23%	50
2015 Q2	$262K	Hold	8,229	–	–	0.23%	59
2015 Q1	$273K	Hold	8,229	–	–	0.17%	62
2014 Q4	$245K	Hold	8,229	–	–	0.14%	64
2014 Q3	$232K	Hold	8,229	–	–	0.12%	55
2014 Q2	$232K	Hold	8,229	–	–	0.06%	71
2014 Q1	$249K	Hold	8,229	–	–	0.07%	50
2013 Q4	$240K	Hold	8,229	–	–	0.05%	59
2013 Q3	$225K	Hold	8,229	–	–	0.06%	49
2013 Q2	$220K	Buy	+8,229	New	+$227K	0.09%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Weatherstone Capital Management's PFE Position: Q1 2019 in Review

Weatherstone Capital Management sold out of Pfizer (PFE) in Q1 2019, closing a stake of 7,472 shares — an estimated $312K sold.

Weatherstone Capital Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $312K in Q4 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Weatherstone Capital Management reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
Weatherstone Capital Management sold 7,472 Pfizer shares in Q1 2019, an estimated $312K.
Weatherstone Capital Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
Weatherstone Capital Management's Pfizer position peaked at $312K in Q4 2018.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Weatherstone Capital Management's 13F filing for Q1 2019, filed 16 Apr 2019.